{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie2u53qzvnnnrinpx3tw3wmeo7dfettej4hh762l2tpfyzgbx3psm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mm6326ap75z2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifxucakhso7vo7p2byak7ec3n7ldipolygxxn6cuimvpsnmmyqiq4"
    },
    "mimeType": "image/jpeg",
    "size": 199369
  },
  "path": "/news/2026-05-scientists-class-drug-candidate-chronic.html",
  "publishedAt": "2026-05-18T18:40:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Chronic itch is often described as an \"invisible torment.\" It can persist for weeks or months, severely affecting sleep, mental health, and quality of life. In patients with cholestatic liver disease, chronic itch remains a major clinical challenge, and current treatments often provide limited relief.",
  "title": "Scientists develop first-in-class drug candidate for chronic itch"
}